COHERUS BIOSCIENCES I
1.2600
27-November-24 16:45:00
15 minutes delayed
Stocks
-0.0200
-1.56%
Today's range
1.2300 - 1.3500
ISIN
N/A
Source
NASDAQ
-
Coherus Completes Divestiture of Ophthalmology Franchise
04 Mar 2024 01:00:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
23 Feb 2024 17:33:13 By Nasdaq GlobeNewswire
-
21 Feb 2024 08:30:00 By Nasdaq GlobeNewswire
-
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
05 Feb 2024 08:00:01 By Nasdaq GlobeNewswire
-
22 Jan 2024 01:15:00 By Nasdaq GlobeNewswire
-
18 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Management to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 09:00:00 By Nasdaq GlobeNewswire
-
Coherus Announces U.S. Launch of LOQTORZI™
02 Jan 2024 08:29:00 By Nasdaq GlobeNewswire
-
26 Dec 2023 16:01:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Announces CFO Transition Plans
07 Dec 2023 17:55:48 By Nasdaq GlobeNewswire
-
06 Dec 2023 04:00:00 By Nasdaq GlobeNewswire
-
28 Nov 2023 11:16:23 By Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
06 Nov 2023 16:07:41 By Nasdaq GlobeNewswire
-
03 Nov 2023 08:30:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences to Participate at Upcoming November Investor Conferences
02 Nov 2023 20:00:08 By Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Third Quarter 2023 Financial Results on November 6, 2023
30 Oct 2023 18:00:00 By Nasdaq GlobeNewswire
-
27 Oct 2023 15:07:20 By Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
24 Oct 2023 19:41:27 By Nasdaq GlobeNewswire
-
14 Oct 2023 12:30:00 By Nasdaq GlobeNewswire